News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Investing.com2d agobullish
Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugsInvestor's Business Daily2d agobullish
Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli LillyBarrons.com2d agoneutral
Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly AgreementInvestor's Business Daily11d agobullish
Hims Stock Surges After RFK Jr. Eases Access To Unapproved PeptidesSimply Wall St.71d agoneutral
Hims & Hers Health (HIMS) Is Down 14.6% After Raising Guidance Amid Privacy Scrutiny - What's ChangedInvesting.com82d agoneutral
Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors"StockStory83d agoneutral
5 Revealing Analyst Questions From Hims & Hers Health’s Q2 Earnings CallInsider Monkey86d agoneutral
Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset?